Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regal Rexnord (RRX) Cash & Equivalents (2016 - 2026)

Regal Rexnord has reported Cash & Equivalents over the past 17 years, most recently at $521.7 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 32.58% year-over-year to $521.7 million; the TTM value through Dec 2025 reached $521.7 million, up 32.58%, while the annual FY2025 figure was $521.7 million, 32.58% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $521.7 million at Regal Rexnord, up from $400.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.1 billion in Q1 2023 and troughed at $305.3 million in Q1 2025.
  • A 5-year average of $563.3 million and a median of $566.4 million in 2021 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: soared 120.21% in 2022 and later plummeted 59.3% in 2024.
  • Year by year, Cash & Equivalents stood at $328.6 million in 2021, then surged by 109.53% to $688.5 million in 2022, then dropped by 16.63% to $574.0 million in 2023, then crashed by 31.45% to $393.5 million in 2024, then surged by 32.58% to $521.7 million in 2025.
  • Business Quant data shows Cash & Equivalents for RRX at $521.7 million in Q4 2025, $400.0 million in Q3 2025, and $320.1 million in Q2 2025.